India Healthcare Cold Chain Logistics Market: Market Size & Forecast 2026

Healthcare cold chain logistics involves the temperature-controlled storage, transportation, and distribution of sensitive healthcare products including vaccines, biopharmaceuticals, clinical trial materials, and other temperature-sensitive medical supplies. The India Healthcare Cold Chain Logistics Market operates within the larger Asia-Pacific region, which commands a dominant share of the global healthcare cold chain market valued at over $31.91 billion in 2025. India's pharmaceutical industry, one of the world's largest vaccine manufacturers and a major supplier of generic drugs, creates substantial demand for robust cold chain infrastructure across the country.

• •The global healthcare cold chain logistics market is valued at approximately $64.0 billion in 2025
• •Asia-Pacific healthcare cold chain market size: $31.91 billion (2025), growing to $33.47 billion (2026)
• •The market is projected to reach $149.65 billion globally by 2035

India's rapid expansion in vaccine manufacturing and biopharmaceutical production is a primary catalyst for cold chain market growth, with the country serving as a major global supplier of vaccines and generic medicines. Government initiatives such as the Immunization Programme and increased healthcare spending have amplified demand for temperature-controlled logistics networks across urban and rural areas. Additionally, the rise of clinical trials in India and growing domestic healthcare consumption are driving investments in specialized cold chain infrastructure and third-party logistics services.

• •India's status as a leading global vaccine manufacturer creates sustained demand for cold chain solutions
• •Government immunization programs and healthcare infrastructure development initiatives
• •Growth in clinical trials, biopharmaceuticals, and domestic healthcare consumption

The market is segmented by product type, including vaccines, biopharmaceuticals, clinical trial materials, and other temperature-sensitive healthcare products, each requiring different temperature ranges and handling protocols. Service segmentation covers transportation, warehousing and storage, packaging solutions, and third-party logistics (3PL) services, with packaging and temperature monitoring technologies gaining prominence. Within Asia-Pacific, India represents a significant and fast-growing market, though specific market share figures vary across different research sources reporting global market sizes between $64.0 billion and $70.77 billion in 2025-2026.

• •Product segments: vaccines, biopharmaceuticals, clinical trial materials, and others
• •Service segments: transportation, warehousing and storage, packaging solutions, and 3PL
• •Temperature ranges vary across products, requiring specialized infrastructure and monitoring technologies

What are the recent trends and outlook?

The market is witnessing significant technological adoption, with IoT-enabled temperature monitoring, blockchain for supply chain transparency, and AI-driven route optimization becoming standard offerings among leading providers. The post-pandemic era has accelerated investments in cold chain infrastructure, with governments and private players expanding refrigerated warehousing capacity and last-mile delivery networks. Looking ahead to 2035, the market is expected to nearly triple from its 2025 base, driven by continued vaccine development, biologics growth, and India's expanding role in global pharmaceutical supply chains.

• •IoT-based temperature monitoring, blockchain traceability, and AI-powered logistics optimization are gaining adoption
• •Post-pandemic infrastructure investments are expanding refrigerated warehousing and last-mile delivery capabilities
• •Global market projected to grow from $64.0 billion (2025) to $149.65 billion (2035)